Accuracy of early detection of colorectal tumours by stool methylation markers: A meta-analysis

World Journal of Gastroenterology

Volumn 20, Issue 38, 2014, Pages 14040-14050

  Zhang, Hu ^a,c   Qi, Jian ^a   Wu, Ya Qiong ^b   Zhang, Ping ^c   Jiang, Jun ^c   Wang, Qi Xian ^a   Zhu, You Qing ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WANNAN MEDICAL COLLEGE   (China)

^c Hubei Provincial Corps Hospital   (China)

Author keywords

Colorectal adenoma; Colorectal carcinoma; Meta analysis; Methylation; Stool

Indexed keywords

TUMOR MARKER; MEMBRANE PROTEIN; SFRP2 PROTEIN, HUMAN;

ARTICLE; CANCER PATIENT; CHINESE BIOMEDICAL DATABASE; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL TUMOR; DATA ANALYSIS SOFTWARE; DIAGNOSTIC ACCURACY; DISEASE MARKER; DNA METHYLATION; FECES ANALYSIS; FULL TEXT DATABASE; HUMAN; MEDLINE; META ANALYSIS; QUALITY CONTROL; SECRETED FRIZZLED RELATED PROTEIN 2 GENE; SENSITIVITY AND SPECIFICITY; TUMOR DIAGNOSIS; TUMOR GENE; WANFANG DATABASE; WEB OF SCIENCE; ADENOMA; CARCINOMA; CHEMISTRY; CHI SQUARE DISTRIBUTION; EARLY DIAGNOSIS; FECES; GENETIC SCREENING; GENETICS; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; RISK; RISK FACTOR;

ADENOMA; CARCINOMA; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DNA METHYLATION; EARLY DETECTION OF CANCER; FECES; GENETIC TESTING; HUMANS; MEMBRANE PROTEINS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84910002265     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i38.14040     Document Type: Article

References (49)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2004; 59: 225-249 [PMID: 19474385 DOI: 10.3322/caac.20006]
2. Schetter AJ, Harris CC. Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol 2011; 38: 734-742 [PMID: 22082759 DOI: 10.1053/j.seminoncol.2011.08.009]
3. Markowitz SD, Dawson DM, Willis J, Willson JK. Focus on colon cancer. Cancer Cell 2002; 1: 233-236 [PMID: 12086859 DOI: 10.1016/S1535-6108(02)00053-3]
4. Bosch LJ, Carvalho B, Fijneman RJ, Jimenez CR, Pinedo HM, van Engeland M, Meijer GA. Molecular tests for colorectal cancer screening. Clin Colorectal Cancer 2011; 10: 8-23 [PMID: 21609931 DOI: 10.3816/CCC.2011.n.002]
5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96 [PMID: 18287387 DOI: 10.3322/CA.2007.0010]
6. Heresbach D, Manfredi S, D'halluin PN, Bretagne JF, Branger B. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol 2006; 18: 427-433 [PMID: 16538116 DOI: 10.00042737-200604000-00018/16538116]
7. Tagore KS, Levin TR, Lawson MJ. The evolution to stool DNA testing for colorectal cancer. Aliment Pharmacol Ther 2004; 19: 1225-1233 [PMID: 15191503 DOI: 10.1111/j.1365-2036.2004.02005.x]
8. Berger BM, Ahlquist DA. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Pathology 2012; 44: 80-88 [PMID: 22198259 DOI: 10.1097/PAT.0b013e3283502fdf]
9. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25 [PMID: 14606960 DOI: 10.1186/1471-2288-3-25]
10. Ahlquist DA, Taylor WR, Mahoney DW, Zou H, Domanico M, Thibodeau SN, Boardman LA, Berger BM, Lidgard GP. The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia. Clin Gastroenterol Hepatol 2012; 10: 272-7.e1 [PMID: 22019796 DOI: 10.1016/j.cgh.2011.10.008]
11. Bosch LJ, Oort FA, Neerincx M, Khalid-de Bakker CA, Terhaar sive Droste JS, Melotte V, Jonkers DM, Masclee AA, Mongera S, Grooteclaes M, Louwagie J, van Criekinge W, Coupé VM, Mulder CJ, van Engeland M, Carvalho B, Meijer GA. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT. Cancer Prev Res (Phila) 2012; 5: 464-472 [PMID: 22135045 DOI: 10.1158/1940-6207.CAPR-11-0315]
12. Ahlquist DA, Zou H, Domanico M, Mahoney DW, Yab TC, Taylor WR, Butz ML, Thibodeau SN, Rabeneck L, Paszat LF, Kinzler KW, Vogelstein B, Bjerregaard NC, Laurberg S, Sørensen HT, Berger BM, Lidgard GP. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012; 142: 248-56; quiz e25-6 [PMID: 22062357 DOI: 10.1053/j.gastro.2011.10.031]
13. Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, Biondo S, Blanco I, Peinado MA, Moreno V, Esteller M, Capellá G. Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clin Colorectal Cancer 2010; 9: 168-176 [PMID: 20643622 DOI: 10.3816/CCC.2010.n.023]
14. Tang D, Liu J, Wang DR, Yu HF, Li YK, Zhang JQ. Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer. Clin Invest Med 2011; 34: E88-E95 [PMID: 21463549]
15. Baek YH, Chang E, Kim YJ, Kim BK, Sohn JH, Park DI. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients. Dis Colon Rectum 2009; 52: 1452-149; discussion 1452-149; [PMID: 19617759 DOI: 10.1007/DCR.0b013e3181a79533]
16. Li M, Chen WD, Papadopoulos N, Goodman SN, Bjerregaard NC, Laurberg S, Levin B, Juhl H, Arber N, Moinova H, Durkee K, Schmidt K, He Y, Diehl F, Velculescu VE, Zhou S, Diaz LA, Kinzler KW, Markowitz SD, Vogelstein B. Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol 2009; 27: 858-863 [PMID: 19684580 DOI: 10.1038/nbt.1559]
17. Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst 2009; 101: 916-927 [PMID: 19535783 DOI: 10.1093/jnci/djp131]
18. Ausch C, Kim YH, Tsuchiya KD, Dzieciatkowski S, Washington MK, Paraskeva C, Radich J, Grady WM. Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA. Clin Chem 2009; 55: 1559-1563 [PMID: 19541867 DOI: 10.1373/clinchem.2008.122937]
19. Hellebrekers DM, Lentjes MH, van den Bosch SM, Melotte V, Wouters KA, Daenen KL, Smits KM, Akiyama Y, Yuasa Y, Sanduleanu S, Khalid-de Bakker CA, Jonkers D, Weijenberg MP, Louwagie J, van Criekinge W, Carvalho B, Meijer GA, Baylin SB, Herman JG, de Bruïne AP, van Engeland M. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin Cancer Res 2009; 15: 3990-3997 [PMID: 19509152 DOI: 10.1158/1078-0432.CCR-09-0055]
20. Mayor R, Casadomé L, Azuara D, Moreno V, Clark SJ, Capellà G, Peinado MA. Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. Br J Cancer 2009; 100: 1534-1539 [PMID: 19384295 DOI: 10.1038/sj.bjc.6605045]
21. Kim MS, Louwagie J, Carvalho B, Terhaar Sive Droste JS, Park HL, Chae YK, Yamashita K, Liu J, Ostrow KL, Ling S, Guerrero-Preston R, Demokan S, Yalniz Z, Dalay N, Meijer GA, Van Criekinge W, Sidransky D. Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer. PLoS One 2009; 4: e6555 [PMID: 19662090 DOI: 10.1371/journal.pone.0006555]
22. Nagasaka T, Tanaka N, Cullings HM, Sun DS, Sasamoto H, Uchida T, Koi M, Nishida N, Naomoto Y, Boland CR, Matsubara N, Goel A. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Inst 2009; 101: 1244-1258 [PMID: 19700653 DOI: 10.1093/jnci/djp265]
23. Glöckner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, Chan TA, Kleeberger W, de Bruïne AP, Smits KM, Khalid-de Bakker CA, Jonkers DM, Stockbrügger RW, Meijer GA, Oort FA, Iacobuzio-Donahue C, Bierau K, Herman JG, Baylin SB, Van Engeland M, Schuebel KE, Ahuja N. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res 2009; 69: 4691-4699 [PMID: 19435926 DOI: 10.1158/0008-5472.CAN-08-0142]
24. Wang DR, Tang D. Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. World J Gastroenterol 2008; 14: 524-531 [PMID: 18203283]
25. Oberwalder M, Zitt M, Wöntner C, Fiegl H, Goebel G, Zitt M, Köhle O, Mühlmann G, Ofner D, Margreiter R, Müller HM. SFRP2 methylation in fecal DNA - a marker for colorectal polyps. Int J Colorectal Dis 2008; 23: 15-19 [PMID: 17639423 DOI: 10.1007/s00384-007-0355-2]
26. Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC, Sontag S, Johnson D, Markowitz S, Paszat L, Berger BM. A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol 2008; 103: 2862-2870 [PMID: 18759824 DOI: 10.1111/j.1572-0241.2008.02088.x]
27. Huang ZH, Li LH, Yang F, Wang JF. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. World J Gastroenterol 2007; 13: 950-954 [PMID: 17352030]
28. Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC, Sontag S, Johnson D, Skoletsky J, Durkee K, Markowitz S, Shuber A. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 2007; 5: 111-117 [PMID: 17161655 DOI: 10.1016/j.cgh.2006.10.006]
29. Abbaszadegan MR, Tavasoli A, Velayati A, Sima HR, Vosooghinia H, Farzadnia M, Asadzedeh H, Gholamin M, Dadkhah E, Aarabi A. Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran. World J Gastroenterol 2007; 13: 1528-1533 [PMID: 17461444]
30. Zhang W, Bauer M, Croner RS, Pelz JO, Lodygin D, Hermeking H, Stürzl M, Hohenberger W, Matzel KE. DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene. Dis Colon Rectum 2007; 50: 1618-126; discussion 1618-126; [PMID: 17762966 DOI: 10.1007/s10350-007-0286-6]
31. Leung WK, To KF, Man EP, Chan MW, Hui AJ, Ng SS, Lau JY, Sung JJ. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps. Am J Gastroenterol 2007; 102: 1070-1076 [PMID: 17378912 DOI: 10.1111/j.1572-0241.2007.01108.x]
32. Petko Z, Ghiassi M, Shuber A, Gorham J, Smalley W, Washington MK, Schultenover S, Gautam S, Markowitz SD, Grady WM. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res 2005; 11: 1203-1209 [PMID: 15709190]
33. Lenhard K, Bommer GT, Asutay S, Schauer R, Brabletz T, Göke B, Lamerz R, Kolligs FT. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clin Gastroenterol Hepatol 2005; 3: 142-149 [PMID: 15704048]
34. Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, Platzer P, Lu S, Dawson D, Willis J, Pretlow TP, Lutterbaugh J, Kasturi L, Willson JK, Rao JS, Shuber A, Markowitz SD. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005; 97: 1124-1132 [PMID: 16077070 DOI: 10.1093/jnci/dji204]
35. Müller HM, Oberwalder M, Fiegl H, Morandell M, Goebel G, Zitt M, Mühlthaler M, Ofner D, Margreiter R, Widschwendter M. Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 2004; 363: 1283-1285 [PMID: 15094274 DOI: 10.1016/S0140-6736(04)16002-9]
36. Xu MH, Cai KY, Tu Y. Stool DNA methylation analysis in the early diagnosis of colorectal cancer. Linchang Xiaohuabing Zazhi 2012; 24: 7-19
37. Kang YP, Cao FA, Chang WJ, Lou Z, Wang Y, Wu LL, Fu CG, Cao GW. Stool DNA methylation in the screening early colorectal cancer. Zhonghua Weichang Waike Zazhi 2011; 14: 52-561 [DOI: 10.3760/cma.j.issn.1671-0274.2011.01.017]
38. Zhang JP, Wang J, Gui YL, Zhu QQ, Xu ZW, Li JS. Stool DNA methylation in the diagnosis of colorectal cancer. Zhonghua Yixue Zazhi 2011; 95: 2482-2484 [DOI: 10.3760/cma.j.issn.0376-2491.2011.35.010]
39. Fu L, Sheng JQ, Meng XM, Meng MM, Jin P, Li AQ, Wu ZT, Li SR. Stool Vimentin methylation in the diagnosis of colorectal cancer. Weichangbing Ji Ganzabingxue Zazhi 2010; 19: 601-603 [DOI: 10.3969/j.issn.1006-5709.2010.07.007]
40. Ling ZA, Chen LS, He CG. Stool P16 methylation in the diagnosis of colorectal cancer. Jiezhichang Gangmen Waike 2009; 15: 144-148 [DOI: 10.3969/j.issn.1674-0491.2009.03.002]
41. Cheng ZH. Stool SFRP2 methylation in the diagnosis of colorectal cancer. Shandong Yiyao Zazhi 2007; 47: 10-12
42. Zhao HX, Li QW, Dong WW, Duan XH, Zhu JH, Wang RL, Hao YX, Ye M, Xiao WH. Stool NDRG4 methylation in the diagnosis of colorectal cancer. Zhongguo Yiyao Daobao 2012; 9: 29-31 [DOI: 10.3877/cma.j.issn.1674-0785.2012.10.012]
43. Chang E, Park DI, Kim YJ, Kim BK, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Kim HD, Kim DH, Kim YH. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients. Hepatogastroenterology 2010; 57: 720-727 [PMID: 21033217]
44. Zhang H, Song YC, Dang CX. Detection of hypermethylated spastic paraplegia-20 in stool samples of patients with colorectal cancer. Int J Med Sci 2013; 10: 230-234 [PMID: 23372428 DOI: 10.7150/ijms.5278]
45. Carmona FJ, Azuara D, Berenguer-Llergo A, Fernández AF, Biondo S, de Oca J, Rodriguez-Moranta F, Salazar R, Villanueva A, Fraga MF, Guardiola J, Capellá G, Esteller M, Moreno V. DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer. Cancer Prev Res (Phila) 2013; 6: 656-665 [PMID: 23694962 DOI: 10.1158/1940-6207.CAPR-12-0501]
46. Guo Q, Song Y, Zhang H, Wu X, Xia P, Dang C. Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients. Med Oncol 2013; 30: 695 [PMID: 23963856 DOI: 10.1007/s12032-013-0695-4]
47. Kim MS, Lee J, Sidransky D. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 2010; 29: 181-206 [PMID: 20135198 DOI: 10.1007/s10555-010-9207-6]
48. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351: 2704-2714 [PMID: 15616205 DOI: 10.1056/NEJMoa033403]
49. Qi J, Zhu YQ, Luo J, Tao WH. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol 2006; 12: 7113-7117 [PMID: 17131472]